https://mediately.co/hr/atcs?atcCategory=L01EJ04
L01EJ04 - Momelotinib - Mediately
Lijekovi s djelovanjem na probavni sustav i mijenu tvari, Lijekovi s djelovanjem na krv i krvotvorne organe, Pripravci koji djeluju na kardiovaskularni sustav,...
momelotinibmediately
https://www.targetedonc.com/view/momelotinib-addresses-anemia-in-myelofibrosis
Momelotinib Addresses Anemia in Myelofibrosis | Targeted Oncology - Immunotherapy, Biomarkers, and...
Oct 10, 2026 - Findings from the MOMENTUM study evaluating momelotinib demonstrated symptom, spleen, and anemia benefits in myelofibrosis compared with danazol in previously...
momelotinibaddressesanemiamyelofibrosistargeted